Experts to Discuss the Future of Sterilization Monitoring Using
Technology Developed by NASA’s Jet Propulsion Laboratory
–(BUSINESS WIRE)–Verrix:
| WHEN: | Sunday, April 28, 2019, to Wednesday, May 1, 2019 | |
| WHAT: |
Verrix will be exhibiting at the IAHCSMM 2019 Annual Conference & Expo to discuss critical needs in sterilization monitoring and engage with champions in the sterile processing field to explore the future of sterile processing. |
|
| WHY: |
Inadequately sterilized surgical instruments are a major contributor to infection outbreaks. Biological indicator (BI) systems are used to monitor the lethality of sterilization cycles and detect failed cycles, providing greater confidence that surgical instruments are free from contamination. Delays and inaccuracies in the sterilization confirmation process can lead to unwarranted risk and operational disruption. Verrix is taking a new approach to develop solutions that deliver BI results with unprecedented speed and accuracy and eliminate common causes of error. |
|
| HIGHLIGHTS: | ||
|
||
|
||
|
||
| WHERE: |
Booth #821 at the Anaheim Marriott and Convention Center, 800 West |
|
About Verrix
Verrix is a San Clemente, Calif.-based medical device company that is
using the most advanced technologies to help protect patients from
healthcare-associated infections. The foundational sterility assurance
technology, originally discovered at NASA’s Jet Propulsion Laboratory,
integrates cutting-edge optical physics, chemistry spectroscopy, and
molecular biology. Based on scientific expertise and close partnerships
with healthcare professionals, Verrix is developing market-changing
solutions for sterility assurance, environmental monitoring, and
infection control. Visit www.verrix.com
for more information.
Contacts
Media Contacts
Andrea Sampson, Sullivan & Sampson PR
[email protected],
714/374-6174
Erin Manning, Vice President, Marketing, Verrix
[email protected],
949/668-1229
